神经皮肤疾病:诊断,管理和治疗
Ivelina Kioutchoukova1, Devon Foster2, Rajvi Thakkar1
1College of Medicine, University of Florida, Gainsville, FL 32610, USA.
Journal of clinical medicine
|March 28, 2024
概括
神经皮肤疾病 (phakomatoses) 涉及神经系统和皮肤. 了解它们的遗传学是开发精准医学和有针对性的疗法以更好地管理患者的关键.
科学领域:
- 遗传学 遗传学 是一个
- 神经学 神经学
- 皮肤病学 皮肤病学
背景情况:
- 神经皮肤疾病 (phakomatoses) 是一种先天性/获得性综合征,影响神经和皮肤系统.
- 对几种发病症的基因理解正在进步,指导治疗的发展.
研究的目的:
- 审查神经皮肤疾病的遗传和临床方面.
- 检查当前的临床管理和治疗策略.
- 突出精准医学在管理这些疾病中的作用.
主要方法:
- 对遗传和临床数据的文献综述.
- 综合正在进行和当前的治疗方法.
- 分析精准医学在向治疗中的作用.
主要成果:
- 基因洞察力对于理解 phakomatoses 是至关重要的.
- 精准医学和向治疗越来越重要.
- 疗法的相互联系强调了分子通路的重要性.
结论:
- 遗传学的进步正在彻底改变神经皮肤疾病管理.
- 精准医学为独特的分子途径提供量身定制的治疗策略.
- 本综述综合了当前针对具有挑战性的神经皮肤疾病的治疗方法.
相关概念视频
Skin Diseases and Disorders
3.8K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.8K
Nursing Diagnosis
2.7K
Following assessment, a nursing diagnosis is the next step in the nursing process. It begins after the nurse has collected and recorded the patient data. The purpose of diagnosing is to identify how the client responds to actual or potential health processes, identify factors that bestow or that cause health problems, the etiologies, and identify resources or strengths the individual, group, or community can draw on to prevent or resolve problems.
The nursing diagnosis focuses on evidence-based...
The nursing diagnosis focuses on evidence-based...
2.7K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Diabetes: Management and Pharmacotherapy
277
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
277
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541


